Navigation Links
Clinovo Adds Broad Expertise to Board of Directors

Sunnyvale, CA (PRWEB) December 18, 2013

Fast-growing eClinical Solutions provider Clinovo today announced two additions to their board of directors: Jean-Louis Bories, angel investor at Band of Angels, and Glenn Keet, a leader in the health information technology industry.

Jean-Louis Bories has been an executive in the technology sector for the past 30 years and is now an active angel investor. As a member of the Band of Angels his first investments were in IT Healthcare with an EHR company that recently closed their series D investment round for $70 million. Jean-Louis invested in Clinovo in September 2013 after leading a comprehensive due diligence process that brought 5 additional angel investors including senior executives from Cisco Systems, HP, Cadence, a medical device professional investor as well as a professor of pediatrics.

“The company has the potential to disrupt and grasp the growing eClinical systems market with their Cloud-based eClinical solution,” states Jean-Louis Bories. “For these reasons I found Clinovo to present a low-risk investment, particularly since it has an established customer base and diversified revenue streams.”

Glenn Keet, who has worked in Health Information Technology for nearly three decades, was most recently the SVP for Business Development for Optum’s Health Cloud initiative. Prior, he was President and cofounder of Axolotl, a pioneer in the Health Information Exchange (HIE) industry, which he led through explosive growth and to a successful sale to Ingenix, a division of United Health Group, in 2010. Prior to his role as president of Axolotl, Glenn headed several departments, including Sales and Marketing, Professional Services and Product Management. Previously he held management positions at Mercator, an EDI firm now owned by IBM.

“I have been impressed with what has already been accomplished at Clinovo,” said Keet. “I am even more impressed with the opportunities still in front of Clinovo, which is exceedingly well positioned to capitalize on the 80% of clinical trials that are not yet being managed utilizing CRO software.”

“Jean-Louis and Glenn bring complementary skill sets, and each has a track record of success that speaks for itself,” says Ale Gicqueau, President & CEO at Clinovo. “We are building the foundations for Clinovo’s next phase of development and growth. We are very excited to expand our experienced board of directors and get additional advice and guidance on execution of the company vision.”

About Clinovo:
Clinovo partners with life science companies to streamline their clinical trials, leveraging years of expertise in systems integration, open source technology and industry standards. Clinovo provides Staffing Solutions, TechTrainings, eClinical Systems and Biometrics Services including Clinical Data Management, Electronic Data Capture, CDISC Mapping and Clinical and Statistical Programming.

Sophie McCallum
Director of Operations

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinovo Ranked #9 Among 494 Biotech by Business Intelligence Company SIGNL
2. Clinovo Releases ClinCapture 1.0.3 and its New eClinical Suite
3. Clinovo Sponsors Outsourcing in Clinical Trials Southern California Conference 2013, in La Jolla (CA), September 24-25
4. Clinovo Launches New Version of CDISC® Express, its CDISC SDTM Mapping Tool
5. Clinovo Presents Its Paper ‘Cloud for Clinical Trials’ at Society for Clinical Data Management (SCDM) Conference 2013
6. Clinovo’s TechTrainings: Next Hands-On SAS & CDISC Classes Start September 17th, 2013
7. Clinovo Sponsors the First Outsourcing in Clinical Trials: Medical Devices & Diagnostics Conference, June 12-13, 2013 in Saint Paul, Minnesota
8. Clinovo Launches TechTrainings on CDISC Standards
9. Clinovo, Leading CRO in the Bay Area, Endorsed by Medical Device Company for Their Flagship System: Clincapture
10. Clinovo Hosted the Fourth Silicon Valley BioTalks on June 6th, 2012
11. PBL InterferonSource Changes Name To PBL Assay Science Reflecting Broader Offerings.
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... Accutest Research Laboratories, a leading ... Organization (CRO), has formed a strategic ... - Temple Health for joint work ... (Photo: ) , --> ...
(Date:11/25/2015)... 2 nouvelles études permettent d ... différences entre les souches bactériennes retrouvées dans la plaque ... humains . Ces recherches  ouvrent une nouvelle ... charge efficace de l,un des problèmes de santé ... .    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
Breaking Biology Technology:
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)... Mass. , Nov. 12, 2015  Arxspan ... Institute of MIT and Harvard for use of ... discovery information management tools. The partnership will support ... both biological and chemical research information internally and ... will be used for managing the Institute,s electronic ...
(Date:11/9/2015)... , Nov. 09, 2015 ... the addition of the "Global Law ... their offering. --> ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) has ...
Breaking Biology News(10 mins):